Profiling of cardio-metabolic risk factors and medication utilisation among Type II diabetes patients in Ghana: a prospective cohort study.

Clin Transl Med 2017 Sep 7;6(1):32. Epub 2017 Sep 7.

School of Medical and Health Sciences, Edith Cowan University, 270 Joondalup Drive, Joondalup, Perth, 6027, WA, Australia.

Background: Type II diabetes mellitus (T2DM) is complicated by multiple cardio-metabolic risk factors. Controlling these factors requires lifestyle modifications alongside utilisation of anti-diabetic medications. Different glucose lowering [(biguanides (BIGs), sulfonylureas (SUAs), thiazolidinediones (TNZ)], lipid lowering (statins), and anti-hypertensive medicines [angiotensin converting enzyme inhibitors (ACEIs), calcium channel blockers (CCBs), angiotensin II receptor blockers (ARBs) and central acting drugs (CADs)] have been approved for controlling hyperglycaemia, dyslipidaemia and hypertension respectively. Here, we examined factors that characterise T2DM and explored the response to medication therapy among T2DM patients.

Methods: This prospective cohort study recruited 241 T2DM patients reporting at a clinic in Ghana, from January through to August, 2016. Each patient's demographic, medications and anthropometric data was obtained while information on medication adherence was captured using Morisky adherence scale-8 (MMAS-8). Fasting blood samples were collected for biochemical analysis.

Results: The mean age of participants was 57.82 years for baseline and six-month follow-up. Physical activity differed at baseline and follow up (p < 0.05) but not body mass index (BMI). BIG alone, or in combination with SUA and TNZ did not improve glycaemic status at follow up (p > 0.05). Many participants using either ACEI or ARB were able to control their blood pressures. Among dyslipidaemia patients under statin treatment, there was an improved lipid profile at follow-up.

Conclusions: Statin medications are effective for reducing dyslipidaemia in T2DM patients. However, control of modifiable risk factors, particularly blood glucose and to a lesser degree blood pressure is suboptimal. Addressing these will require concomitant interventions including education on medication adherence and correct dietary plans, lifestyle modifications and physical activity.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40169-017-0162-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587509PMC
September 2017
24 Reads
2 Citations

Publication Analysis

Top Keywords

risk factors
12
type diabetes
8
lifestyle modifications
8
cohort study
8
medication adherence
8
prospective cohort
8
t2dm patients
8
physical activity
8
cardio-metabolic risk
8
factors
5
t2dm
5
t2dm explored
4
therapy t2dm
4
dyslipidaemia t2dm
4
effective reducing
4
explored response
4
reducing dyslipidaemia
4
medication therapy
4
response medication
4
medications effective
4

References

(Supplied by CrossRef)

J Tuomilehto et al.
N Engl J Med 2001

FH Epstein et al.
N Engl J Med 1999

I Danquah et al.
BMC Public Health 2012

C Herder et al.
Clin Pharmacol Ther 2011

HE Resnick et al.
Ann Rev Med 2002

LA Lavery et al.
Diabetes Care 2003

RI Holt et al.
Curr Diab Rep 2014

A Campayo et al.
Curr Psychiatry Rep 2011

Action to Control Cardiovascular Risk in Diabetes Study et al.
N Engl J Med 2008

Similar Publications